ARCHIVES

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

This article is from The Cancer Letter archive.

Vol. 25 No. 02 | January 15, 1999

Download PDF Visit The Full Archive

Related Articles

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

US Oncology Clarifies Role of Pharmacy Committee

January 24, 2003

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995